An estimated 1.6 million children and teenagers would be eligible for the medication, to be sold as Palforzia, an intended for ages 4 to 17.
Author: Matthew Perrone, Associated Press
Neck tumors, feet with amputated toes: FDA proposes graphic images on cigarette boxes
If the FDA’s proposal goes through, it would be the first change to U.S. cigarette warnings in 35 years.
Anti-vaping victory? Federal judge orders FDA to speed up review of e-cigarettes
Lack of oversight has led to an explosion in underage vaping by teens, threatening to hook a generation of Americans on nicotine, health groups say.
Too soon to pull breast implants tied to cancer, experts say
Government medical advisers said it’s too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem.
US experts revisit breast implant safety after new concerns
The FDA is grappling with a recently confirmed link between the implants and a rare form of cancer.